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A new antiplasmodial compound, 2-(3H-diazirine-3-yl)benzaldehyde (1), has been isolated from the Papuan 
marine sponge Xestospongia sp. The structure elucidation of compound 1 was determined by spectroscopic 
evidences including UV, IR, MS, 1D and 2D-NMR analysis. Compound 1 showed moderate antiplasmodial 
activity against Plasmodium falciparum with IC50 value of 1.08  10
-6M. 
 





1.  INTRODUCTION 
 
In tropical countries, malaria is known 
as the most severe disease infected more than 
two billion people across the world (Bagavan 
et al., 2011; Poostchi et al., 2017). This disease 
is also responsible of the human death (Weiss 
et al., 2018), most of the death cases occurred 
in Africa, Asia, and other tropical countries 
(Snow et al., 2005; Nayyar et al., 2012; 
Kabaria et al., 2017). 
Currently, Indonesia harbours twenty 
vectors malaria associating with four species of 
Malaria (Elyazar et al., 2011). In Indonesia, 
cases of malaria are estimated about ninety 
millions cases by 2011 where one people died 
per a hundred thousand cases (WHO, 2008). 
Most cases of malaria are reported in the 
eastern provinces of Indonesia (Papua and 
West Papua) (Nagesha et al., 2001; Douglas et 
al., 2017). In the region, malaria have infected 
seventy people per a hundred population, most 
of them are women and children (WHO, 
2008). 
It is estimated about 30% of 
antimalarial medicaments are obtained from 
nature herbs, including terrestrial plants and 
marine biota’s (Sanon et al., 2013; Boampong 
et al., 2015). In marine drug exploration, 
marine sponges (Xestopongia sp. and 
Haliclona sp.) are intensively studied in recent 
decades, since its potential antiplasmodial and 
bacterial properties, in which dozen patents 
already obtained from this unique biota 
(Inbaneson and Ravikumar, 2012; Davis et al., 
2012; Beesoo et al., 2017). Marine sponge of 
the genus Xestospongia is one of the world’s 
potential antimalarial agents containing 
xestoquinone (Laurent et al., 2006; Nogueira 
and Lopes, 2011; Bottee et al., 2012). 
In the present study, a new 
antiplasmodial compound obtained from the 
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Papuan marine sponge is desribed, and 
exhibited ability against Plasmodium 
falciparum. 
 
2. MATERIAL AND METHODS 
 
General Experimental Procedure 
The IR spectra were recorded on a 
SHIMADZU IR Prestige-21 in KBr. The mass 
spectra were recorded with a Waters Xevo 
QTOF MS. NMR spectra were recorded on a 
Bruker Topspin spectrometer at 500 MHz for 
1
H and 125 MHz for 
13
C using TMS as an 
internal standard. Column chromatography 
was conducted on silica gel 60. TLC plates 
were precoated with silica gel GF254 (Merck, 
0.25 mm) and detection was achieved by 
spraying with 10% H2SO4 in EtOH, followed 
by heating and under UV light at wave length 
at 254 and 367 nm. 
 
Sponge Collection and Cultured Parasites 
  The study was based on material 
Porifera genus Xestospongia, collected by 
scuba in about 10 m depth in the south west of 
Kaimana, West Papua, Indonesia (GPS: 
4°20.341’S-133°30.265’E). It has been 
identified taxonomically as Xestospongia sp., 
(Lamarck, 1813), the species belongs to the 
Xestospongia (Order Haplosclerida: Family 
Petrosiidae). Identification taxonomic and 
nomenclature were provided by the Laboratory 
Biology and Conservation, Jakarta Fisheries 
University, Ministry of Marine Affairs and 
Fisheries (LIN BIOVASI, No: 041/STP-
V/2016, Catalogue: MS041.1-5). Subject of the 
study was the protozoan parasite P. falciparum 
strain 3D7 (chloroquine-sensitive) obtained 
from University of Tokyo and cultured by the 
Eijkman Institute for Molecular Biology in 
Jakarta. 
 
Extraction and Isolation 
   The milled fresh of sponge 
Xestospongia sp. (38 kg) was extracted with 
EtOH (40 L) at room temperature. After 
removing solvent under the vacuum, viscous 
concentrated of EtOH extract (376 g) was first 
suspended in H2O and then partitioned 
successively with n-hexane, EtOAc, and         
n-BuOH. Evaporation resulted in the crude 
extracts of n-hexane (10 g), EtOAc (11 g), and 
n-BuOH (30 g), respectively. The EtOAc was 
selected for fractionation due to uniqueness of 
this assay. The EtOAc extract (11 g) was 
fractionated by column chromatography on 
silica gel using a gradient n-hexane-EtOAc-
MeOH to give eleven fractions (A–K). 
Fraction B (2.6 g) was subjected to column 
chromatography on silica gel, eluted               
n-hexane:acetone (8:2) to give twelve 
subfractions (B1-B12). Subfraction B11 (450 
mg) was column chromatography on octa desyl 
silane (ODS), eluted with MeOH:H2O (7:3) to 
yield five subfractions (B11A-B11E). 
Subfraction B11C (86 mg) was separated by 
preparative TLC on silica gel GF254, eluted 
with n-hexane:acetone (7:3) to give 1 (12 mg). 
 
Antiplasmodial Assay in Vitro 
 Strain 3D7 of P. falciparum was 
cultured and developed by Eijkman Institute 
for Molecular Biology in Jakarta. Antimalarial 
examination was used 96 wells, each well 
filled by parasitemia culture 1%. About 50 µL 
of the sponge fractions filled in to the well 
















-2 μg/mL.  All wells 
were then stored in the Laminar Airflow 
cabinets, until all solvents are evaporated. 
Further, we added 50 µL of parasitemia red 
blood cell into the well then were incubated at 
37ºC. After 48 h, slides preparation were 
stained using Giemsa 20% (WHO, 2008).  
 
3. RESULT AND DISCUSSION 
   
 The ethanol extract from the milled 
fresh of sponge of Xestospongia sp. was 
concentrated and extracted successively with 
n-hexane, ethyl acetate, and n-butanol. The 
ethyl acetate fraction was separated by 
combination of column chromatography on 
silica gel G60, ODS, and preparative TLC on 








  Yellow oily; UV (MeOH) λmax nm (log 
ε) 260 (3.74); IR (KBr) vmax(cm
-1
) 1725, 1620, 
1510, and 820. 
1
H-NMR (DMSO-d6, 500 





C-NMR (DMSO-d6, 125 MHz), 
see Table 1. QTOF MS m/z 146.3106. 
 
Table 1.  NMR data for Compound 1 (500 MHz for  
1
H and 125 MHz for 
13










1 - 125.6 (s) 
2 - 120.2 (s) 
3 7.50 (1H, d, 7.8) 113.0 (d) 
4 7.27 (1H, dd, 7.1, 7.8) 124.5 (d) 
5 7.23 (1H, dd, 6.8, 7.1) 123.0 (d) 
6 8.21 (1H, d, 6.8) 122.3 (d) 
7 10.03 (1H, s) 185.4 (s) 
8 8.20 (1H, s) 138.1 (d) 
 
 
  Compound 1 was obtained as yellow 
oily. QTOF-MS of 1 showed m/z 146.3106, 
which in line to the molecular formula of 
C8H6ON2 thus requiring seven degrees of 
unsaturation. UV spectra in MeOH showed 
λmax nm (log ε) 260 (3.74), indicated the 
presence of benzene ring attached to electron 
with drawing group (Ursula and Stanley, 
1987). The IR spectrum showed absorption 
peaks due to of aldehyde group (1720 cm
-1
), 
C=C aromatic ring (1515 cm
-1
), N=N group 
(1620 cm
-1
), and disubstituted aromatic ring 
(1020 and 820 cm
-1
).  The 
1
H-NMR spectrum 
of 1 showed the presence of an aldehyde 
proton at H 10.03 (1H, s, H-7), aromatic 
protons at H 7.50 (1H, d, J=7.8 Hz, H-3), 7.27 
(1H, dd, J=7.8 Hz, H-4), 7.23 (1H, dd, J=6.8 
and 7.1 Hz, H-5) and 8.21 (1H, d, J=6.8 Hz, H-
6) as well as a deshielded aliphatic proton at H 
8.20 (1H, s, H-8). The 
13
C NMR spectrum 
showed seven carbon resonances, which were 
classified by their chemical shift sand the 
DEPT spectra as one aldehyde (C 185.4), two 
sp
2
 quartenary carbons at C 125.6 and 120.2, 
four sp
2
 methine carbons at C 113.0, 124.5, 
123.0 and 122.3 as well as one sp
3 
deshielded 
carbon at C 138.1. These functionalities 
accounted for five out of the total seven 
degrees of unsaturation and the remaining two 
degrees of unsaturation were consistent with 
the diazirine-benzaldehyde derivative sructure 
(Sakurai et al., 2014).   
 A comparison of the NMR data of 1 
with those of 2-methoxy-5-[3-
(trifluoromethyl)-3H-diazirine-3-yl]-
benzaldehyde (Sakurai et al., 2014), revealed 
that the structures of the two compounds are 
closely related, the main differences are the 
absence of methoxyl and trifluoromethyl group 
and the presence additional aromatic protons in 
1. The gross structure of 1 was deduced from 
the 
1
H–1H COSY and HMBC spectra (Fig. 2). 
The 
1
H–1H COSY spectrum of 1 showed 
correlations in C1–C2–C3–C4, supporting the 
presence of terasubstituted benzene ring and 
remaining the aldehyde group and diazirine 
ring. In the HMBC spectrum, an aldehyde 
proton at H 10.03 was correlated to C-1 (C 
125.6) and C-2 (C 120.2), indicating that an 
aldehyde group was located at C-1. A 
downfield proton resonance at H 8.20 was 
correlated to C-2 (C 120.2), whereas aromatic 
proton at H 7.50 was correlated to a downfield 
resonance carbon at C 138.1 (C-8), indicating 
that a diazirine ring was located at C-2. The 
aromatic proton at H 7.23 was correlated to  
C-6 (C 122.3) and C-4 (C 124.5), whereas 
another aromatic proton at H 7.50 was 
correlated to C-2 (C 120.2) and C-4                      
(C 124.5), supporting the presence of ortho-
tetrasubtituted benzene ring. The relative 
stereochemistry of C-8 was determined by 
comparing with the similar compounds, 2-
methoxy-5-[3-(trifluoromethyl)-3H-diazirin-3-
il]-benzaldehyde (Sakurai et al., 2014) and 3,7-
dimethyl-9-(4'-(3H-diazirinyl)-2',6'-
dimethylphenyl)-2E,4E,6E,8E-nonatetraenal-
1-3H (Ursula and Stanley, 1987), thus the 
relative stereochemistry of C-8 was R. 
Consequently, the structure of a new diazirine 
benzaldehyde (1), was established as 2-(3H-
diazirine-3-yl)-benzaldehyde and was isolated 








H-COSY and HMBC 
Correlations of 1 
 
 
  2-(3H-diazirine-3-yl)benzaldehyde (1) 
showed moderate antiplasmodial activity 
against P. falciparum strain 3D7 in vitro with 
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IC50 value of 1.0810
-6 M. The smallest value 
of IC50 indicates the effectiveness to inhibit a 
given P. falciparum (Baniecki et al., 2007; 
Koleala et al., 2015). A slight value IC50 
indicates also that a compound has highly 
potential antimalarial agent. The obtained 
value of IC50 in the present work lower than 
dihydroartemisinin, commonly obtained by 
researchers (IC50 < 25 µg/mL) (Ringwald, 
1999; Ravikumar et al., 2012), indicated that 
the compound 2-(3H-diazirine-3-
yl)benzaldehyde as a promising sources 
against  Plasmodium. 
  Currently, the marine sponges are 
pointed as one of the potential object of 
biomedical research due to its richness 
bioactive properties. In recent decades, marine 
sponges are known as marine drugs resources 
such as anticancer, antimicrobe, antivirus, and 
antimalaria (Sipkema et al.,  2004; Kutluay et 
al., 2016). In the present study, we reported 
here the presence of a compound was 
recognised from derivate of benzaldehyde, 
which is highly capable of inhibiting 
Plasmodium (IC50 1.0810
-6 M). The obtained 
value of IC50 in the present work was far 
lowest compared to commonly IC50 obtained 
from the same type of biota, such as sponge of 
Northern New Guinea IC50 34.6 µM 
(Murtihapsari et al., 2013), sponge of New 
Caledonia 3 M. (Laurent et al., 2006; 
Nogueira and Lopes, 2011). Our finding of 
antiplasmodial activity is rangked as very 
active compound according to norms 
(Rasoanaivo  et al., 1992;  Ringwald, 1999; 
Ravikumar et al., 2012a; 2012b). 
Malaria has been one of the most 
deadly disease in eastern part of Indonesia. In 
respond to the Indonesia and international 
program of reducing malarial effects, research 
on malaria was recently attracted much 
attention and has been supported by 
government. The eastern part of Indonesia was 
known as center of World Coral Triangle, a 
vast richness of marine landscape harboring 
potential marine drugs for Malaria. Recently 
(Tapilatu, 2015) summarized a list of newly 
compound from the marine life of eastern part 
of the country where antimalarial source 
remain poorly studied. We conclude that our 
finding exhibit a strongly signal antimalarial 
compound from Papuan sponge, which is need 





A new antiplasmodial compound, 
namely, 2-(3H-diazirine-3-yl)benzaldehyde (1) 
was isolated from the Papuan marine sponge 
Xestospongia sp. 2-(3H-diazirine-3-
yl)benzaldehyde showed moderate 
antiplasmodial activity against P. falciparum 
with IC50 value of 1.08  10
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